The future of tumor vaccines in the post‐COVID‐19 era—Current challenges

QR Code

The future of tumor vaccines in the post‐COVID‐19 era—Current challenges

Saved in:

Bibliographic Details
Main Author:	Panagiotis F. Christopoulos
Format:	article
Language:	EN
Published:	Wiley 2021
Subjects:	cancer vaccines COVID‐19 immunotherapy SARS‐CoV‐2 Immunologic diseases. Allergy RC581-607
Online Access:	https://doaj.org/article/cd4fe03427214a60b37c579fe3d0d1c4
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

SARS‐CoV‐2 infection shortly after BNT162b2 vaccination results in high anti‐spike antibody levels in nursing home residents and staff
by: Doris Urlaub, et al.
Published: (2021)

The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity
by: Carlos del Fresno, et al.
Published: (2021)

Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT™ adjuvant induce broad, Th1 biased, humoral and cellular immune responses in mice
by: Chih-Yun Lai, et al.
Published: (2021)

COVID-19 Vaccine Boosters: The Good, the Bad, and the Ugly
by: Piotr Rzymski, et al.
Published: (2021)

Understanding COVID-19: From Dysregulated Immunity to Vaccination Status Quo
by: Ruby A. Escobedo, et al.
Published: (2021)

Effect of COVID-19 on Anti-S Antibody Response in Healthcare Workers Six Months Post-Vaccination
by: Robert Flisiak, et al.
Published: (2021)

Impaired Functional T-Cell Response to SARS-CoV-2 After Two Doses of BNT162b2 mRNA Vaccine in Older People
by: Julie Demaret, et al.
Published: (2021)

Predicted Epitope Abundance Supports Vaccine-Induced Cytotoxic Protection Against SARS-CoV-2 Variants of Concern
by: Antonio J. Martín-Galiano, et al.
Published: (2021)

Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines
by: Yandi Zhang, et al.
Published: (2021)

Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine
by: Felipe Melo-González, et al.
Published: (2021)

Current and future nanoparticle vaccines for COVID-19
by: Mai N. Vu, et al.
Published: (2021)

Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges
by: Ramesh Kandimalla, et al.
Published: (2021)

Glycan Masking of Epitopes in the NTD and RBD of the Spike Protein Elicits Broadly Neutralizing Antibodies Against SARS-CoV-2 Variants
by: Wei-Shuo Lin, et al.
Published: (2021)

Pre-Existing Cross-Reactive Antibody Responses Do Not Significantly Impact Inactivated COVID-19 Vaccine-Induced Neutralization
by: Jin Wang, et al.
Published: (2021)

The Interaction of Natural and Vaccine-Induced Immunity with Social Distancing Predicts the Evolution of the COVID-19 Pandemic
by: Michael F. Good, et al.
Published: (2020)

Development of an Inactivated Vaccine against SARS CoV-2
by: Shaikh Terkis Islam Pavel, et al.
Published: (2021)

The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape
by: Dandan Tian, et al.
Published: (2021)

Side Effects of COVID-19 Pfizer-BioNTech mRNA Vaccine in Children Aged 12–18 Years in Saudi Arabia
by: Edrous Alamer, et al.
Published: (2021)

Increased B Cell Selection Stringency In Germinal Centers Can Explain Improved COVID-19 Vaccine Efficacies With Low Dose Prime or Delayed Boost
by: Amar K. Garg, et al.
Published: (2021)

Association between COVID-19 Vaccine Side Effects and Body Mass Index in Spain
by: Isabel Iguacel, et al.
Published: (2021)

Knowledge, Attitudes and Perception toward COVID-19 Vaccines among Adults in Jazan Province, Saudi Arabia
by: Edrous Alamer, et al.
Published: (2021)

Vaccinated Patients Admitted in ICU with Severe Pneumonia Due to SARS-CoV-2: A Multicenter Pilot Study
by: Ángel Estella, et al.
Published: (2021)

High‐resolution HLA genotyping identifies alleles associated with severe COVID‐19: A preliminary study from India
by: Ravikanth Vishnubhotla, et al.
Published: (2021)

Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats
by: Johnstone Tcheou, et al.
Published: (2021)

Vaccine versus Variants (3Vs): Are the COVID-19 Vaccines Effective against the Variants? A Systematic Review
by: Kadhim Hayawi, et al.
Published: (2021)

Immune thrombocytopenia relapse post covid-19 vaccine in young male patient
by: Hana Qasim, et al.
Published: (2021)

COVID-19 Breakthrough Infections and Transmission Risk: Real-World Data Analyses from Germany’s Largest Public Health Department (Cologne)
by: Lea Hsu, et al.
Published: (2021)

Humoral Response after Vaccination with Half-Dose of BNT162b2 in Subjects under 55 Years of Age
by: Krzysztof Lukaszuk, et al.
Published: (2021)

Prevalence and Factors Associated with Parents’ Non-Intention to Vaccinate Their Children and Adolescents against COVID-19 in Latin America and the Caribbean
by: Diego Urrunaga-Pastor, et al.
Published: (2021)

Development of Inactivated FAKHRAVAC<sup>®</sup> Vaccine against SARS-CoV-2 Virus: Preclinical Study in Animal Models
by: Soheil Ghasemi, et al.
Published: (2021)

CoV-RBD121-NP Vaccine Candidate Protects against Symptomatic Disease following SARS-CoV-2 Challenge in K18-hACE2 Mice and Induces Protective Responses That Prevent COVID-19-Associated Immunopathology
by: Jennifer K. DeMarco, et al.
Published: (2021)

The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
by: Bruna Aparecida Souza Machado, et al.
Published: (2021)

The clinical outcomes of COVID‐19 in HIV‐positive patients: A systematic review of current evidence
by: SeyedAhmad SeyedAlinaghi, et al.
Published: (2021)

COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control
by: Philippe Buchy, et al.
Published: (2021)

SARS‐CoV‐2 spike glycoprotein‐reactive T cells can be readily expanded from COVID‐19 vaccinated donors
by: Pavla Taborska, et al.
Published: (2021)

Organisational Model and Coverage of At-Home COVID-19 Vaccination in an Italian Urban Context
by: Elettra Carini, et al.
Published: (2021)

Investigating Adherence to COVID-19 Vaccination and Serum Antibody Concentration among Hospital Workers—The Experience of an Italian Private Hospital
by: Guglielmo Forgeschi, et al.
Published: (2021)

Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature
by: Bruno Fattizzo, et al.
Published: (2021)

Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
by: Piotr Rzymski, et al.
Published: (2021)

Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape
by: Fuxing Lou, et al.
Published: (2021)